scholarly article | Q13442814 |
P356 | DOI | 10.1111/JPHP.12070 |
P698 | PubMed publication ID | 24236987 |
P2093 | author name string | Xinyu Chen | |
Michael Decker | |||
Birgit Kraus | |||
Katharina Zenger | |||
P2860 | cites work | Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death | Q33832682 |
The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes | Q34346464 | ||
Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo | Q34504691 | ||
Drug-drug interactions of silymarin on the perspective of pharmacokinetics | Q34890751 | ||
The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis | Q36733673 | ||
Immortal activated human hepatic stellate cells generated by ectopic telomerase expression | Q38291132 | ||
Tacrine-silibinin codrug shows neuro- and hepatoprotective effects in vitro and pro-cognitive and hepatoprotective effects in vivo | Q39342911 | ||
Clinical Pharmacokinetics of Tacrine | Q40472033 | ||
Tacrine-induced Reactive Oxygen Species in a Human Liver Cell Line: The Role of Anethole Dithiolethione as a Scavenger | Q40938500 | ||
Noninterference of cytochrome P4501A2 in the cytotoxicity of tacrine using genetically engineered V79 Chinese hamster cells for stable expression of the human or rat isoform and two human hepatocyte cell lines | Q41128196 | ||
Hybrid molecules from xanomeline and tacrine: enhanced tacrine actions on cholinesterases and muscarinic M1 receptors | Q43160965 | ||
Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates | Q46649408 | ||
Tacrine and its analogues impair mitochondrial function and bioenergetics: a lipidomic analysis in rat brain. | Q48760407 | ||
Re-evaluation of tacrine hepatotoxicity using gel entrapped hepatocytes. | Q50473483 | ||
Design, synthesis, biological properties, and molecular modeling investigations of novel tacrine derivatives with a combination of acetylcholinesterase inhibition and cannabinoid CB1 receptor antagonism. | Q51775443 | ||
Tacrine. A cause of fatal hepatotoxicity? | Q53221544 | ||
Alzheimer's disease | Q55880664 | ||
P433 | issue | 12 | |
P304 | page(s) | 1765-1772 | |
P577 | publication date | 2013-04-29 | |
P1433 | published in | Journal of Pharmacy and Pharmacology | Q10532762 |
P1476 | title | In-vitro stability and metabolism of a tacrine-silibinin codrug | |
P478 | volume | 65 |